Multi-OMICS approaches in onco-hematology, from gene editing to spatial analyses

CALYM offers cutting-edge platforms in genomics and transcriptomics, along with comprehensive bioinformatics pipelines to explore the biology of lymphoid hemopathies. Our offer includes CRISPR/Cas9 approaches (model, barcoding, screening platform), advanced single-cell approaches such as scRNA-seq, or CITE-seq, and multi-omics technologies (like ATAC-seq, ChIP-seq, WES, WGS). CALYM also provides spatially resolved transcriptomics (Xenium) and proteomics (Hyperion, mIF), enabling new insights into tumor microenvironments and cancer biology.